Roche launched the "Digital Healthcare Incubator 2.0" at the seventh China International Import Expo in Shanghai. [Photo ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

The Switzerland market ended marginally down on Wednesday as stocks shed early gains and the index slipped below the flat line in the ...

Barclays analyst Emily Field maintained a Hold rating on Roche Holding AG (RHHVF – Research Report) today and set a price target of ...

This year has seen several biopharma companies drop Alzheimer’s and Parkinson’s disease programs, but experts say plenty are ...

A right-wing campaign to cap Switzerland’s population is “dangerous” and threatens businesses’ ability to attract top talent, the country’s finance chief said.

Herzog & de Meuron (HdM) has designed a new research facility for Roche, a large Swiss pharmaceutical company based in Basel. The four new structures, collectively known as pRED, consist of two ...

With U.S. sales of $392 million in the third quarter, Regeneron’s high-dose version of Eylea is closing in on blockbuster sales in its first full year on the market. The bad news for the company, ...

A survey by Roche Diagnostics of 2,836 women aged 25 to 50 from eight Asia-Pacific countries discovered that 44 per cent of respondents delayed or avoided medical treatment because of familial ...

Dyno will leverage its platform and sequence design technologies to design and discover novel AAV capsids. Credit: metamorworks/Shutterstock. Dyno Therapeutics has ...

(Bloomberg) — Roche Holding AG is willing to pay more than $1 billion to solve one of the biggest challenges of gene therapy: delivery. The Swiss drugmaker has reached a new deal with Dyno ...

(Bloomberg) -- Roche Holding AG is willing to pay more than $1 billion to solve one of the biggest challenges of gene therapy: delivery. The Swiss drugmaker has reached a new deal with Dyno ...